Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of deubiquitinating enzyme USP20 in lowering cholesterol synthesis and improving metabolic syndrome

A deubiquitinating enzyme, cholesterol technology, applied in the field of deubiquitinating enzymes, can solve problems such as ambiguity and increased cholesterol biosynthesis

Active Publication Date: 2021-06-01
WUHAN UNIV
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the mechanism of the increased cholesterol biosynthesis induced by feeding is not well understood

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of deubiquitinating enzyme USP20 in lowering cholesterol synthesis and improving metabolic syndrome
  • Application of deubiquitinating enzyme USP20 in lowering cholesterol synthesis and improving metabolic syndrome
  • Application of deubiquitinating enzyme USP20 in lowering cholesterol synthesis and improving metabolic syndrome

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0152] Example 1 Cell Culture

[0153] CHO-7, Huh-7 and HEK293T cells were incubated at 37°C and 5% CO 2 monolayer growth in an environment. Huh-7 and HEK293T cells were maintained in medium A (DMEM containing 100 units / mL penicillin and 100 mg / mL streptomycin sulfate), supplemented with 10% fetal bovine serum (FBS). CHO-7 and CHO-gp78-KO cells were maintained in medium B (a 1:1 mixture of DMEM and Ham's F-12 medium containing 100 units / mL penicillin and 100 mg / mL streptavidin sulfate) supplemented with 5% FBS white). Cholesterol-starved medium C was obtained from medium A or medium B supplemented with 5% lipoprotein-deficient serum (LPDS), 1 μM lovastatin and 10 μM mevalonic acid. Primary mouse hepatocyte culture medium D (M199) supplemented with 5% FBS, 100 units / mL penicillin and 100 μg / mL streptomycin sulfate.

Embodiment 2

[0154] Example 2 Western blotting

[0155] The harvested cells or tissues are lysed in RIPA lysis buffer supplemented with protease inhibitors. RIPA lysis buffer contained 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 2 mM MgCl2, 1.5% NP-40, 0.1% SDS and 0.5% sodium deoxycholate. Protease inhibitors included MG-132 at 10 μM, leupeptin at 10 μg / ml, 1 mM phenylmethylsulfonyl fluoride, pepstatin at 5 μg / ml, N-acetylleucinal-leucinal-norleucinal at 25 μg / ml and dithiothreitol at 1 mM. The protein concentration of the lysates was determined using the BCA method (Thermo Fisher Scientific). Protein samples were mixed with membrane lysis buffer (62.5mM Tris-HCl, pH 6.8, 15% SDS, 8M urea, 10% glycerol and 100mM DTT) and 4x loading buffer (150mM Tris-HCl, pH 6.8, 12% SDS, 30% glycerol, 6% 2-mercaptoethanol and 0.02% bromophenol blue) were incubated at 37°C for 30 minutes. Protein samples were separated by SDS-PAGE gel and then transferred to PVDF membrane. Block with TBS containing 0.075% Tw...

Embodiment 3

[0157] Example 3 Immunoprecipitation

[0158] Cells were washed twice with ice-cold PBS buffer, and then harvested in 600 μl of ice-cold lysis buffer (PBS containing 0.5% digitonin, 5mM EGTA, 5mM EDTA, protease and phosphatase inhibitors). After the whole cell lysate was centrifuged (12,000g, 10 minutes), the precipitate was discarded, and 60 μl of the supernatant was used as the whole cell lysate control (Input component), and 500 μl of the supernatant was mixed with 30 μl of the primary antibody. Rotate and incubate for 2 hours, centrifuge at 1000g for 5 minutes, take 60 μl of supernatant as the supernatant control (Supernatant component), then discard the remaining supernatant, wash 3 times with lysis buffer, each time for 10 minutes and keep rotating to mix . Finally, the precipitate was collected, and 120 μl of SDS PAGE Loading buffer was added, marked as the pellet fraction. Then each component was detected by Western blot.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an application of an antagonist or an inhibitor of a deubiquitinating enzyme USP20 protein or a coding gene thereof. The antagonist or the inhibitor is used for preparing a medicine for reducing cholesterol synthesis and improving metabolic syndrome.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to the use of a deubiquitinating enzyme. Background technique [0002] Cholesterol is the most abundant sterol in mammals. It plays a multifaceted role, including regulating membrane function 1 , a precursor for the synthesis of bile acids and steroid hormones 2 , and covalently modify Hedgehog and Smoothened proteins 3-5 . Cholesterol and other lipid metabolism abnormalities are major risk factors for cardiovascular disease, nonalcoholic fatty liver disease (NAFLD), obesity and diabetes 6 [0003] It is estimated that the total amount of cholesterol newly synthesized or absorbed from the gut by an adult is about 1 g per day 7 . The liver is the major organ for cholesterol biosynthesis, accounting for about 50% of the total production in an individual. Starting from acetyl-CoA, cholesterol is synthesized through approximately 30 reaction steps, in which HMG-CoA reductase (HMGCR)...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K45/00A61P1/16A61P3/04A61P3/06A61P3/10A61P5/50A61P9/00C12Q1/6883G01N33/68A61K38/48
CPCA61K45/00A61P3/06A61P1/16A61P5/50A61P9/00A61P3/04A61P3/10C12Q1/6883G01N33/6893A61K38/4813C12Y304/19012C12Q2600/136C12Q2600/158G01N2800/044
Inventor 宋保亮芦小艺史熊杰
Owner WUHAN UNIV